Effects of levosimendan in heart failure: The role of echocardiography
| Autor: | Stefano Lunghetti, Carlotta Sciaccaluga, Matteo Cameli, Giulia Elena Mandoli, Romina Navarri, Sergio Mondillo, Nicolò Sisti, Eufemia Incampo, Elisabetta Palmerini, Francesca Maria Righini |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2019 |
| Předmět: |
Inotrope
medicine.medical_specialty Cardiotonic Agents Systole Heart Ventricles Population Hemodynamics heart failure Vasodilation 030204 cardiovascular system & hematology Ventricular Function Left 03 medical and health sciences levosimendan 0302 clinical medicine Internal medicine medicine Humans echocardiography Radiology Nuclear Medicine and imaging 030212 general & internal medicine education Simendan education.field_of_study business.industry Therapeutic effect Stroke Volume Levosimendan therapeutic effects medicine.disease Myocardial function Heart failure Cardiology Cardiology and Cardiovascular Medicine business medicine.drug |
| Popis: | Heart failure (HF) represents a deadly epidemic that nowadays affects more than 2% of the general population, representing a major public health concern that implies a high economic burden for the health system. Levosimendan in HF patients is usually used for its inotropic and vasodilator effects that act without myocardial oxygen consumption, differently from other inotropic drugs. The symptoms and hemodynamic profile improve together with the myocardial function, and this can be demonstrated by an echocardiographic examination. Currently, the available data about the effects of levosimendan assessed by echocardiography are still lacking. This review discusses the role of echocardiography in the evaluation of therapeutic effects of levosimendan in HF. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|